Updated: January 25, 2026
What Is Pimecrolimus? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
What is pimecrolimus (Elidel) and what is it used for? Learn about this eczema treatment's uses, dosage, how to apply it, and what to expect in 2026.
If your doctor has prescribed pimecrolimus — or you've heard the brand name Elidel — you may be wondering exactly what this medication is and why it's used for eczema. Here's a comprehensive, plain-English overview.
What Is Pimecrolimus?
Pimecrolimus is a prescription topical cream used to treat mild to moderate atopic dermatitis — the medical term for eczema. It belongs to a class of medications called topical calcineurin inhibitors (TCIs). Unlike topical steroids (corticosteroids), pimecrolimus is a non-steroidal medication — it reduces inflammation through a different mechanism that doesn't cause skin thinning.
Brand name: Elidel (manufactured for Bausch Health). Generic pimecrolimus 1% cream is also available from multiple manufacturers, including Teva.
The FDA approved pimecrolimus on December 13, 2001, making it one of the first non-steroidal prescription treatments for eczema.
What Is Pimecrolimus Used For?
Pimecrolimus is FDA-approved as second-line therapy for mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older who have:
Failed to respond adequately to other topical prescription treatments (usually topical corticosteroids), OR
Cannot tolerate or should not use topical steroids in the area being treated (e.g., face, eyelids, skin folds)
It is specifically intended for short-term and non-continuous chronic treatment — not for long-term daily use.
Off-Label Uses of Pimecrolimus
Beyond its FDA-approved indication, pimecrolimus is also used off-label (meaning prescribed by a doctor for a use not officially approved by the FDA) for several conditions:
Seborrheic dermatitis (dandruff-related skin inflammation)
Cutaneous lupus erythematosus
Oral lichen planus (an inflammatory condition of the mucous membranes)
Vitiligo (particularly for repigmentation maintenance)
Perioral dermatitis
How Is Pimecrolimus Used? Dosage and Application Instructions
Pimecrolimus is available only as a 1% cream, applied to the skin. It comes in 30-gram, 60-gram, and 100-gram tubes. Standard dosing:
Adults and children 2+: Apply a thin layer to the affected skin areas twice daily
Duration: Use for up to 6 weeks continuously; re-evaluate if no improvement at 6 weeks
Areas: Can be applied to all affected areas including face, neck, and skin folds — but not inside the nose, eyes, mouth, or genitals
Stop use: When symptoms (itch, rash, redness) resolve — don't continue indefinitely just to maintain clear skin
How to Apply Pimecrolimus Correctly
Wash your hands before applying
Make sure the skin is dry (don't apply immediately after bathing)
Apply a thin layer and rub in gently and completely
Wash hands after application (unless you're treating eczema on your hands)
Don't cover with bandages or wraps — regular clothing is fine
Wait before bathing or swimming after application
Is Pimecrolimus a Steroid?
No. Pimecrolimus is not a corticosteroid (steroid). It belongs to a completely different drug class — topical calcineurin inhibitors. Unlike steroids, pimecrolimus does not cause skin atrophy (thinning) or other steroid-related side effects with use on delicate skin areas. This is one of its key clinical advantages for long-term eczema management on the face and skin folds.
Who Should Not Use Pimecrolimus?
Children under 2 years of age (not FDA-approved)
Patients who are immunocompromised (HIV, organ transplant recipients, etc.)
Patients with Netherton's syndrome
Patients with active bacterial or viral skin infections at the application site
Anyone allergic to pimecrolimus or any inactive ingredient in the cream
Want to understand how pimecrolimus actually works in your body? Read our plain-English guide to pimecrolimus's mechanism of action.
Frequently Asked Questions
Pimecrolimus 1% cream (brand name Elidel) is FDA-approved for the short-term treatment of mild to moderate atopic dermatitis (eczema) in adults and children 2 years and older who have tried other topical treatments without adequate success. It is a non-steroidal topical calcineurin inhibitor.
Yes. Elidel is the brand name for pimecrolimus 1% cream, originally developed by Novartis and now manufactured for Bausch Health. Generic pimecrolimus 1% cream (from Teva and other manufacturers) is therapeutically equivalent to Elidel and typically less expensive.
Many patients notice improvement in itch and redness within the first week of twice-daily use. Significant improvement in the appearance of the rash is often seen within 2–4 weeks. If no improvement occurs within 6 weeks, contact your doctor for re-evaluation.
Yes. Pimecrolimus can be applied to all affected skin areas including the face, eyelids, and neck. This is one of its key advantages over topical steroids — it does not cause skin thinning, making it suitable for long-term use on delicate facial and eyelid skin.
Yes. Generic pimecrolimus 1% cream is available from multiple manufacturers including Teva. It is therapeutically equivalent to brand Elidel and significantly less expensive — as low as $70–$80 with GoodRx or SingleCare coupons for a 30g tube.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Pimecrolimus also looked for:
More about Pimecrolimus
33,257 have already found their meds with Medfinder.
Start your search today.





